Elixirgen Therapeutics
Elixirgen Therapeutics
2020
Elixirgen, is a biotechnology company focused on the discovery, development, and commercialization of therapies for genetic diseases and vaccines. The identity we developed is inspired by its mission to cure humanity's ailments through stem cell biology. The icon speaks about the company's two-fold goal of seeking immunity and immortality, and rejuvenation and regeneration.
In addition, their sub-company, Elixirgen Therapeutics, had a few breakthroughs in their pipeline, one specifically as a vaccine for COVID-19. We collaborated to relaunch their identity and website, with a quick turnaround of one month, to coincide with the company's press releases.
Identity
Logo Design
Illustration
Web
Site Architecture
UI / UX Design
Web Development
Elixirgen launched a sub-company focused on cell therapy and vaccine research, Elixirgen Therapeutics. To distinguish Elixirgen Therapeutics, we reconfigured the original logo and updated the color palette of the brand.
The identity uses a typographic family with sans serif and monospace fonts to exude a scientific and modern feel. We also designed custom diagrams and graphics to match.
We collaborated with the Elixirgen Therapeutics team to develop a new website as they launched their research on a new COVID-19 vaccine. The urgency of the news put the project on an expedited timeline, with all hands on deck.
Aesthetically, the website needed a careful balance between scientific and people-centric to distinguish Elixirgen Therapeutics from other cell therapy labs in the industry.
After a month of identity design and iteration, web design, and web development, the website was successfully launched on June 3rd to coincide with Elixirgen Therapeutics' COVID-19 vaccine press release.
RELATED PROJECTS